Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Second major partner for Imaxio vaccine platform

Imaxio, the biopharmaceutical company specializing in vaccines and genomics, has signed a license option agreement with a second major animal health company to develop a number of veterinary vaccines using its immuno-enhancing IMX313 technology platform.  The company is already working with Merial on a veterinary vaccine (Animal Pharm December 19, 2012). Imaxio is located in Lyon, France, close to Merial's global headquarters.


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts